Report cover image

Global Children's Antipyretic Medicine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 110 Pages
SKU # APRC20339578

Description

Summary

According to APO Research, The global Children's Antipyretic Medicine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Children's Antipyretic Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Children's Antipyretic Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Children's Antipyretic Medicine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Children's Antipyretic Medicine include Zhejiang Kangle, Xinhua Pharmaceutical, Hebei Jiheng, Changshu Huagang, Anhui Fubore, Anhui BBCA Likang, Temad, Strides Shasun and SKPL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children's Antipyretic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children's Antipyretic Medicine.
The Children's Antipyretic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children's Antipyretic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Children's Antipyretic Medicine Segment by Company

Zhejiang Kangle
Xinhua Pharmaceutical
Hebei Jiheng
Changshu Huagang
Anhui Fubore
Anhui BBCA Likang
Temad
Strides Shasun
SKPL
Novacyl
Mallinckrodt
IOLCP
Granules India
Granules Biocause
Farmson
Atabay
Anqiu Lu'an
Children's Antipyretic Medicine Segment by Type

Ibuprofen
Acetaminophen
Other
Children's Antipyretic Medicine Segment by Application

Online Sales
Offline Sales
Children's Antipyretic Medicine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children's Antipyretic Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Children's Antipyretic Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children's Antipyretic Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Children's Antipyretic Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Children's Antipyretic Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

110 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Children's Antipyretic Medicine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Children's Antipyretic Medicine Sales Estimates and Forecasts (2020-2031)
1.3 Children's Antipyretic Medicine Market by Type
1.3.1 Ibuprofen
1.3.2 Acetaminophen
1.3.3 Other
1.4 Global Children's Antipyretic Medicine Market Size by Type
1.4.1 Global Children's Antipyretic Medicine Market Size Overview by Type (2020-2031)
1.4.2 Global Children's Antipyretic Medicine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Children's Antipyretic Medicine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Children's Antipyretic Medicine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Children's Antipyretic Medicine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Children's Antipyretic Medicine Sales Breakdown by Type (2020-2025)
1.5.4 South America Children's Antipyretic Medicine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Children's Antipyretic Medicine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Children's Antipyretic Medicine Industry Trends
2.2 Children's Antipyretic Medicine Industry Drivers
2.3 Children's Antipyretic Medicine Industry Opportunities and Challenges
2.4 Children's Antipyretic Medicine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Children's Antipyretic Medicine Revenue (2020-2025)
3.2 Global Top Players by Children's Antipyretic Medicine Sales (2020-2025)
3.3 Global Top Players by Children's Antipyretic Medicine Price (2020-2025)
3.4 Global Children's Antipyretic Medicine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Children's Antipyretic Medicine Major Company Production Sites & Headquarters
3.6 Global Children's Antipyretic Medicine Company, Product Type & Application
3.7 Global Children's Antipyretic Medicine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Children's Antipyretic Medicine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Children's Antipyretic Medicine Players Market Share by Revenue in 2024
3.8.3 2023 Children's Antipyretic Medicine Tier 1, Tier 2, and Tier 3
4 Children's Antipyretic Medicine Regional Status and Outlook
4.1 Global Children's Antipyretic Medicine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Children's Antipyretic Medicine Historic Market Size by Region
4.2.1 Global Children's Antipyretic Medicine Sales in Volume by Region (2020-2025)
4.2.2 Global Children's Antipyretic Medicine Sales in Value by Region (2020-2025)
4.2.3 Global Children's Antipyretic Medicine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Children's Antipyretic Medicine Forecasted Market Size by Region
4.3.1 Global Children's Antipyretic Medicine Sales in Volume by Region (2026-2031)
4.3.2 Global Children's Antipyretic Medicine Sales in Value by Region (2026-2031)
4.3.3 Global Children's Antipyretic Medicine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Children's Antipyretic Medicine by Application
5.1 Children's Antipyretic Medicine Market by Application
5.1.1 Online Sales
5.1.2 Offline Sales
5.2 Global Children's Antipyretic Medicine Market Size by Application
5.2.1 Global Children's Antipyretic Medicine Market Size Overview by Application (2020-2031)
5.2.2 Global Children's Antipyretic Medicine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Children's Antipyretic Medicine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Children's Antipyretic Medicine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Children's Antipyretic Medicine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Children's Antipyretic Medicine Sales Breakdown by Application (2020-2025)
5.3.4 South America Children's Antipyretic Medicine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Children's Antipyretic Medicine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Zhejiang Kangle
6.1.1 Zhejiang Kangle Comapny Information
6.1.2 Zhejiang Kangle Business Overview
6.1.3 Zhejiang Kangle Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Zhejiang Kangle Children's Antipyretic Medicine Product Portfolio
6.1.5 Zhejiang Kangle Recent Developments
6.2 Xinhua Pharmaceutical
6.2.1 Xinhua Pharmaceutical Comapny Information
6.2.2 Xinhua Pharmaceutical Business Overview
6.2.3 Xinhua Pharmaceutical Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Xinhua Pharmaceutical Children's Antipyretic Medicine Product Portfolio
6.2.5 Xinhua Pharmaceutical Recent Developments
6.3 Hebei Jiheng
6.3.1 Hebei Jiheng Comapny Information
6.3.2 Hebei Jiheng Business Overview
6.3.3 Hebei Jiheng Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hebei Jiheng Children's Antipyretic Medicine Product Portfolio
6.3.5 Hebei Jiheng Recent Developments
6.4 Changshu Huagang
6.4.1 Changshu Huagang Comapny Information
6.4.2 Changshu Huagang Business Overview
6.4.3 Changshu Huagang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Changshu Huagang Children's Antipyretic Medicine Product Portfolio
6.4.5 Changshu Huagang Recent Developments
6.5 Anhui Fubore
6.5.1 Anhui Fubore Comapny Information
6.5.2 Anhui Fubore Business Overview
6.5.3 Anhui Fubore Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Anhui Fubore Children's Antipyretic Medicine Product Portfolio
6.5.5 Anhui Fubore Recent Developments
6.6 Anhui BBCA Likang
6.6.1 Anhui BBCA Likang Comapny Information
6.6.2 Anhui BBCA Likang Business Overview
6.6.3 Anhui BBCA Likang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anhui BBCA Likang Children's Antipyretic Medicine Product Portfolio
6.6.5 Anhui BBCA Likang Recent Developments
6.7 Temad
6.7.1 Temad Comapny Information
6.7.2 Temad Business Overview
6.7.3 Temad Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Temad Children's Antipyretic Medicine Product Portfolio
6.7.5 Temad Recent Developments
6.8 Strides Shasun
6.8.1 Strides Shasun Comapny Information
6.8.2 Strides Shasun Business Overview
6.8.3 Strides Shasun Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Strides Shasun Children's Antipyretic Medicine Product Portfolio
6.8.5 Strides Shasun Recent Developments
6.9 SKPL
6.9.1 SKPL Comapny Information
6.9.2 SKPL Business Overview
6.9.3 SKPL Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 SKPL Children's Antipyretic Medicine Product Portfolio
6.9.5 SKPL Recent Developments
6.10 Novacyl
6.10.1 Novacyl Comapny Information
6.10.2 Novacyl Business Overview
6.10.3 Novacyl Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novacyl Children's Antipyretic Medicine Product Portfolio
6.10.5 Novacyl Recent Developments
6.11 Mallinckrodt
6.11.1 Mallinckrodt Comapny Information
6.11.2 Mallinckrodt Business Overview
6.11.3 Mallinckrodt Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Mallinckrodt Children's Antipyretic Medicine Product Portfolio
6.11.5 Mallinckrodt Recent Developments
6.12 IOLCP
6.12.1 IOLCP Comapny Information
6.12.2 IOLCP Business Overview
6.12.3 IOLCP Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 IOLCP Children's Antipyretic Medicine Product Portfolio
6.12.5 IOLCP Recent Developments
6.13 Granules India
6.13.1 Granules India Comapny Information
6.13.2 Granules India Business Overview
6.13.3 Granules India Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Granules India Children's Antipyretic Medicine Product Portfolio
6.13.5 Granules India Recent Developments
6.14 Granules Biocause
6.14.1 Granules Biocause Comapny Information
6.14.2 Granules Biocause Business Overview
6.14.3 Granules Biocause Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Granules Biocause Children's Antipyretic Medicine Product Portfolio
6.14.5 Granules Biocause Recent Developments
6.15 Farmson
6.15.1 Farmson Comapny Information
6.15.2 Farmson Business Overview
6.15.3 Farmson Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Farmson Children's Antipyretic Medicine Product Portfolio
6.15.5 Farmson Recent Developments
6.16 Atabay
6.16.1 Atabay Comapny Information
6.16.2 Atabay Business Overview
6.16.3 Atabay Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Atabay Children's Antipyretic Medicine Product Portfolio
6.16.5 Atabay Recent Developments
6.17 Anqiu Lu'an
6.17.1 Anqiu Lu'an Comapny Information
6.17.2 Anqiu Lu'an Business Overview
6.17.3 Anqiu Lu'an Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Anqiu Lu'an Children's Antipyretic Medicine Product Portfolio
6.17.5 Anqiu Lu'an Recent Developments
7 North America by Country
7.1 North America Children's Antipyretic Medicine Sales by Country
7.1.1 North America Children's Antipyretic Medicine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Children's Antipyretic Medicine Sales by Country (2020-2025)
7.1.3 North America Children's Antipyretic Medicine Sales Forecast by Country (2026-2031)
7.2 North America Children's Antipyretic Medicine Market Size by Country
7.2.1 North America Children's Antipyretic Medicine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Children's Antipyretic Medicine Market Size by Country (2020-2025)
7.2.3 North America Children's Antipyretic Medicine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Children's Antipyretic Medicine Sales by Country
8.1.1 Europe Children's Antipyretic Medicine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Children's Antipyretic Medicine Sales by Country (2020-2025)
8.1.3 Europe Children's Antipyretic Medicine Sales Forecast by Country (2026-2031)
8.2 Europe Children's Antipyretic Medicine Market Size by Country
8.2.1 Europe Children's Antipyretic Medicine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Children's Antipyretic Medicine Market Size by Country (2020-2025)
8.2.3 Europe Children's Antipyretic Medicine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Children's Antipyretic Medicine Sales by Country
9.1.1 Asia-Pacific Children's Antipyretic Medicine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Children's Antipyretic Medicine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Children's Antipyretic Medicine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Children's Antipyretic Medicine Market Size by Country
9.2.1 Asia-Pacific Children's Antipyretic Medicine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Children's Antipyretic Medicine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Children's Antipyretic Medicine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Children's Antipyretic Medicine Sales by Country
10.1.1 South America Children's Antipyretic Medicine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Children's Antipyretic Medicine Sales by Country (2020-2025)
10.1.3 South America Children's Antipyretic Medicine Sales Forecast by Country (2026-2031)
10.2 South America Children's Antipyretic Medicine Market Size by Country
10.2.1 South America Children's Antipyretic Medicine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Children's Antipyretic Medicine Market Size by Country (2020-2025)
10.2.3 South America Children's Antipyretic Medicine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Children's Antipyretic Medicine Sales by Country
11.1.1 Middle East and Africa Children's Antipyretic Medicine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Children's Antipyretic Medicine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Children's Antipyretic Medicine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Children's Antipyretic Medicine Market Size by Country
11.2.1 Middle East and Africa Children's Antipyretic Medicine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Children's Antipyretic Medicine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Children's Antipyretic Medicine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Children's Antipyretic Medicine Value Chain Analysis
12.1.1 Children's Antipyretic Medicine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Children's Antipyretic Medicine Production Mode & Process
12.2 Children's Antipyretic Medicine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Children's Antipyretic Medicine Distributors
12.2.3 Children's Antipyretic Medicine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.